Pfizer to sell vaccine to poor countries
This article was originally published in Scrip
In a relief effort aimed at getting children much-need medicine, Pfizer said it will sell as many as 740 million doses of its blockbuster pneumonia vaccine for a fraction of the product’s price to poor countries.
You may also be interested in...
Using Baxter’s Advate drug as a preventative therapy helped significantly reduce bleeding incidents in a yearlong study.
Mylan CEO Heather Bresch said she is looking to do a sizable deal that helps the US generic and specialty drug maker better compete in a consolidating field of rivals.
Biogen Idec CEO George Scangos is frank about his ambitions to dominate the market for hemophilia therapies, an opportunity he compares to the big biotech’s lead treating multiple sclerosis.